BEST Subsidiary RI Research Instruments Awarded Major Contract for Two Superconducting Accelerator Modules for Pohang Acceler...
17 March 2010 - 10:00PM
Business Wire
RI Research Instruments GmbH, a majority-owned subsidiary of
Bruker Energy & Supercon Technologies (BEST), Inc., today
announced the award of a 4.2 million Euro (approximately $5.7
million USD) contract with the South Korea-based Pohang Accelerator
Laboratory (PAL) for the supply of two superconducting accelerator
modules.
This contract covers the engineering, manufacturing,
integration, testing, delivery and installation of two 500 MHz
superconducting accelerator modules for the upgrade of PAL’s third
generation synchrotron light source, the Pohang Light Source (PLS).
The PLS is operated as a national user facility designed to provide
synchrotron radiation with continuous wavelengths down to 1µ, owned
and operated by PAL and the Pohang University of Science and
Technology (POSTECH ) on behalf of the Korean government. The PLS,
which has been operated for 15 years, will be upgraded by 2011/2012
to produce synchrotron radiation with 100 times higher
brightness.
Dr. Michael Peiniger, Managing Director of RI Research
Instruments, explained: “This award represents the increasingly
sophisticated continuation of a series of similar superconducting
accelerating modules, originally based on a design by Cornell
University and refined by RI to industrial standards. Several
synchrotron light sources in Shanghai, Great Britain, Taiwan and
Canada are successfully operating with such supercon accelerator
modules delivered by RI. With this Pohang contract, we are well
positioned for future applications in synchrotron light sources and
other accelerator projects using superconducting radio-frequency
(srf) technology.”
RI also announced an approximately $750,000 contract amendment
to the $6 million contract with the U.S. Department of Energy’s
(DOE) Thomas Jefferson National Accelerator Facility in Newport
News, Virginia (www.jlab.org) for the production of 86
superconducting accelerating cavities, which was announced in July
2009. This contract modification covers all the radio frequency
(rf) measurements and calibrations, as well as the cleaning of the
interior surfaces of the cavities. Chemical cleaning is a key
process in the ultimate performance of superconducting cavities and
requires the application of detergents, followed by ultrapure water
rinsing in an almost particle-free environment. RI has performed
such state-of-the-art operations at its special-purpose facilities
for several years.
Hanspeter Vogel, Director of RI Research Instruments GmbH,
commented: “This second JLAB award is a perfect complement to the
ongoing production of cavities for Jefferson Laboratory, and
demonstrates again our broad range of abilities for the production
and treatment of superconducting cavities. This contract will
further develop our capabilities for production and treatment of
cavities and complete srf accelerator modules for global
applications in basic energy and nuclear science, high energy
physics, as well as for the International Linear Collider (ILC). We
are committed to serving our global research customers with
complete accelerator subsystems, as well as with specialized series
production services for sophisticated accelerator modules.”
About RI Research Instruments and Bruker EST, Inc.:
RI Research Instruments GmbH is a world leader in the
development and manufacturing of normal and superconducting rf
cavities and systems, linear accelerators, as well as special
products for physics and energy research, scientific, medical and
industrial applications. RI products also include high-performance
electron and ion sources, particle beamlines and diagnostics,
research reactor subunits as well as vacuum and cryogenic systems.
RI Research Instruments was formed as a result of BEST’s April 1,
2009 acquisition of the research instruments business of ACCEL
Instruments GmbH from Varian Medical Systems. Bruker acquired a
majority stake in RI Research Instruments and retained Dr. Michael
Peiniger as Managing Director. BEST has operations in the US, the
UK and Germany, and is a wholly-owned subsidiary of Bruker
Corporation (NASDAQ: BRKR).
For more information, please visit: www.research-instruments.de
or www.bruker-est.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024